![David Kirn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Kirn
Fondatore presso
4D MOLECULAR THERAPEUTICS, INC.
Patrimonio netto: 15 M $ in data 31/05/2026
Profilo
David H.
Kirn was the founder of SillaJen Biotherapeutics, Inc., founded in 2006, where the title held was President & Chief Medical Officer in 2012.
Dr. Kirn is the founder of 4D Molecular Therapeutics, Inc., founded in 2013, holding the titles of President, Chief Executive Officer & Director starting in 2026.
Dr. Kirn is also the founder of Ignite Immunotherapy, Inc...
Dr. Kirn is Chief Executive Officer at ReIGNITE Therapeutics, Inc. Dr. Kirn is Director at Coagulant Therapeutics, Inc. Dr. Kirn is Professor at the University of Oxford.
Former positions include Principal at Warner-Lambert Co., Principal at Onyx Pharmaceuticals, Inc. in 2009, Member at Harvard University, Faculty Member at The University of California, San Francisco, Advisor at National Institutes of Health, Principal at IP2IPO Innovations Ltd., and Faculty Member at Specialist Diabetes Research & Treatment Centre LLC.
Education includes an undergraduate degree from the University of California, Berkeley in 1985 and a doctorate from The University of California, San Francisco in 1989.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/06/2026 | 1.542.485 ( 2,95% ) | 15 M $ | 31/05/2026 |
Posizioni attive di David Kirn
| Società | Posizione | Inizio |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Fondatore | 12/09/2013 |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Coagulant Therapeutics, Inc.
 Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di David Kirn
| Società | Posizione | Fine |
|---|---|---|
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Designs and develops oncolytic virus vaccines | Fondatore | 01/01/2019 |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Corporate Officer/Principal | - |
Specialist Diabetes Research & Treatment Centre LLC
 Specialist Diabetes Research & Treatment Centre LLC Medical/Nursing ServicesHealth Services Operates diabetes treatment centers | Corporate Officer/Principal | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formazione di David Kirn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
88
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business development and technology transfer services | Commercial Services |
Specialist Diabetes Research & Treatment Centre LLC
Specialist Diabetes Research & Treatment Centre LLC Medical/Nursing ServicesHealth Services Operates diabetes treatment centers | Health Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Designs and develops oncolytic virus vaccines | Health Technology |
Coagulant Therapeutics, Inc.
Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma | Health Technology |
